Back to Researchers
Profile photo Ward van Beers

Ward van Beers

Assistant Professor - medical

Strategic program(s):

Child Health

Biography

Eduard van Beers studied medicine at the
University of Leiden and wrote a thesis on Sickle Cell Disease at the
University of Amsterdam. As a research fellow he joined the lab of Gregory Kato
at the NIH, NHLBI Bethesda USA from 2012-2013. Currently he is one of the
hematologists of the Van Creveldkliniek of the University Medical Center in
Utrecht, the Netherlands. Next to hemophilia he has special interest in all
forms of hereditary hemolytic anemia

Strategic program(s):

Child Health

Contact

e.j.vanbeers-3@umcutrecht.nl
Pure profile

Research groups

Van Creveldkliniek Expert Centre for Rare Red Blood Cell Disorders

Research aim

We are dedicated to revolutionizing lives of red blood cell disorder patients through innovative personalized medicine algorithms & rigorous trials for transformative treatments

Go to group

Recent publications

All publications
A novel composition of endogenous metabolic modulators improves red blood cell properties in sickle cell disease Myrthe J van Dijk, Marissa J M Traets, Brigitte A van Oirschot, Titine J J Ruiter, Jonathan R A de Wilde, Jennifer Bos, Wouter W van Solinge, Margaret J Koziel, Judith J M Jans, Revati Wani, Eduard J van Beers, Richard van Wijk, Minke A E Rab
EJHaem, 2024, vol. 5, p.21-32
Metabolic blood profile and response to treatment with the pyruvate kinase activator mitapivat in patients with sickle cell disease Myrthe J van Dijk, Titine J J Ruiter, Sigrid van der Veen, Minke A E Rab, Brigitte A van Oirschot, Jennifer Bos, Cleo Derichs, Anita W Rijneveld, Marjon H Cnossen, Erfan Nur, Bart J Biemond, Marije Bartels, Roger E G Schutgens, Wouter W van Solinge, Judith J M Jans, Eduard J van Beers, Richard van Wijk
Hemasphere, 2024, vol. 8
Activation of pyruvate kinase as therapeutic option for rare hemolytic anemias Myrthe J van Dijk, Jonathan R A de Wilde, Marije Bartels, Kevin H M Kuo, Andreas Glenthøj, Minke A E Rab, Eduard J van Beers, Richard van Wijk
Blood Reviews, 2023, vol. 61
A novel missense variant in ATP11C is associated with reduced red blood cell phosphatidylserine flippase activity and mild hereditary hemolytic anemia Myrthe J. van Dijk, Brigitte A. van Oirschot, Alexander N. Harrison, Steffen M. Recktenwald, Min Qiao, Amaury Stommen, Anne Sophie Cloos, Juliette Vanderroost, Romano Terrasi, Kuntal Dey, Jennifer Bos, Minke A.E. Rab, Anna Bogdanova, Giampaolo Minetti, Giulio G. Muccioli, Donatienne Tyteca, Stéphane Egée, Lars Kaestner, Robert S. Molday, Eduard J. van Beers, Richard van Wijk
American Journal of Hematology, 2023, vol. 98, p.1877-1887
Challenges and Opportunities of Precision Medicine in Sickle Cell Disease Anna Collado, Maria Paola Boaro, Sigrid Van Der Veen, Amira Idrizovic, Bart J. Biemond, David Beneitez Pastor, Ana Ortuño, Elena Cela, Anna Ruiz-Llobet, Pablo Bartolucci, Marianne De Montalembert, Gastone Castellani, Riccardo Biondi, Renzo Manara, Tiziana Sanavia, Piero Fariselli, Petros Kountouris, Marina Kleanthous, Federico Alvarez, Santiago Zazo, Raffaella Colombatti, Eduard J. Van Beers, María Del Mar Mañú-Pereira
HemaSphere, 2023, vol. 7
Use of the oxygen gradient ektacytometry in the dose titration of hydroxyurea therapy in children with sickle cell disease Maite E Houwing, Jennifer Bos, Richard van Wijk, Eduard J van Beers, Marjon H Cnossen, Minke A E Rab,
International Journal of Laboratory Hematology, 2023, vol. 46, p.390-394